Novel FH mutations in families with hereditary leiomyomatosis and renal cell cancer (HLRCC) and patients with isolated type 2 papillary renal cell carcinoma

Journal of Medical Genetics

Volumn 48, Issue 4, 2011, Pages 226-234

  Gardie, Betty ^a,b   Remenieras, Audrey ^a   Kattygnarath, Darouna ^a   Bombled, Johny ^a   Lefèvre, Sandrine ^a,b   Perrier Trudova, Victoria ^a,b   Rustin, Pierre ^c,d   Barrois, Michel ^a   Slama, Abdelhamid ^e   Avril, Marie Françoise ^e,f   Bessis, Didier ^g   Caron, Olivier ^a   Caux, Frédéric ^h   Collignon, Patrick ⁱ   Coupier, Isabelle ^e,j   Cremin, Carol ^k   Dollfus, Hélène ^e,l   Dugast, Catherine ^m   Escudier, Bernard ^a,e   Faivre, Laurence ⁿ   Field, Michel ^o   Gilbert Dussardier, Brigitte ^e,p   Janin, Nicolas ^q   Leport, Yves ^r   Leroux, Dominique ^s   Lipsker, Dan ^l   Malthieu, Félicia ^t   McGilliwray, Barbara ^k   Maugard, Christine ^u,v   Méjean, Arnaud ^e,w   Mortemousque, Isabelle ^x   Plessis, Ghislaine ^y   Poppe, Bruce ^z   Pruvost Balland, Christelle ^aa   Rooker, Serena ^ab   Roume, Joelle ^ac   Soufir, Nadem ^ad   Steinraths, Michelle ^ae   Tan, Min Han ^af   Théodore, Christine ^ag   Thomas, Luc ^ah   Vabres, Pierre ^ai   van Glabeke, Emmanuel ^aj   Meric, Jean Baptiste ^ak   Verkarre, Virginie ^e,w   Lenoir, Gilbert ^a   Joulin, Virginie ^a   Deveaux, Sophie ^e   Cusin, Veronica ^a,e   Feunteun, Jean ^a   Teh, Bin Tean ^al   Paillerets, Brigitte Bressac de ^a   Richard, Stéphane ^a,b,e   more..

^a INSTITUT GUSTAVE ROUSSY   (France)

^b UNIVERSITÉ PARIS SACLAY   (France)

^c INSERM   (France)

^d UNIVERSITÉ PARIS DESCARTES   (France)

^e BICÊTRE HOSPITAL   (France)

^f AP HP ^*  (France)

^g HÔPITAL SAINT ELOI   (France)

^h AVICENNE HOSPITAL   (France)

ⁱ Centre Hospitalier Intercommunal   (France)

^j HÔPITAL ARNAUD DE VILLENEUVE   (France)

^k BRITISH COLUMBIA CANCER AGENCY   (Canada)

^l HÔPITAL CIVIL   (France)

^m RENNES UNIVERSITY HOSPITAL   (France)

ⁿ Medical University of Dijon   (France)

^o ROYAL NORTH SHORE HOSPITAL   (Australia)

^p POITIERS UNIVERSITY HOSPITAL   (France)

^q UNIVERSITY OF LIÈGE   (Belgium)

^r Cabinet de Dermatologie   (France)

^s GRENOBLE UNIVERSITY HOSPITAL   (France)

^t Centre Médico Chirurgical Atlantique   (France)

^u UNIVERSITY HOSPITAL OF STRASBOURG   (France)

^v CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^w HÔPITAL NECKER ENFANTS MALADES   (France)

^x CHU BRETONNEAU   (France)

^y CHU Clemenceau   (France)

^z GHENT UNIVERSITY   (Belgium)

^aa SAINT LOUIS HOSPITAL   (France)

^ab Capital Coasts DHB   (New Zealand)

^ac HÔPITAL AMBROISE PARÉ   (France)

^ad BICHAT HOSPITAL   (France)

^ae VICTORIA GENERAL HOSPITAL   (Canada)

^af DIVISION OF MEDICAL ONCOLOGY   (Singapore)

^ag FOCH HOSPITAL   (France)

^ah CENTRE HOSPITALIER LYON SUD   (France)

^ai HÔPITAL DU BOCAGE   (France)

^aj Centre Hospitalier Intercommunal Andre Gregoire   (France)

^ak Centre Médical de Bligny   (France)

^al VAN ANDEL RESEARCH INSTITUTE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; FUMARATE HYDRATASE;

ADULT; AGED; ARTICLE; AUTOSOMAL DOMINANT DISORDER; ENZYME ACTIVITY; FEMALE; FRAMESHIFT MUTATION; GENE DELETION; GENE MUTATION; GENE SEQUENCE; GENETIC PREDISPOSITION; GENOTYPE PHENOTYPE CORRELATION; HEREDITARY LEIOMYOMATOSIS AND RENAL CELL CANCER; HUMAN; HUMAN CELL; INDEL MUTATION; KIDNEY CANCER; KIDNEY CARCINOMA; LEIOMYOMA; MAJOR CLINICAL STUDY; MALE; MISSENSE MUTATION; NONSENSE MUTATION; PAPILLARY RENAL CELL CANCER; PRIORITY JOURNAL; UTERUS MYOMA;

EID: 79953703400     PISSN: 00222593     EISSN: 14686244     Source Type: Journal    
DOI: 10.1136/jmg.2010.085068     Document Type: Article

References (45)

1. Lehtonen HJ, Kiuru M, Ylisaukko-Oja SK, Salovaara R, Herva R, Koivisto PA, Vierimaa O, Aittomaki K, Pukkala E, Launonen V, Aaltonen LA. Increased risk of cancer in patients with fumarate hydratase germline mutation. J Med Genet 2006;43:523-6.
2. Launonen V, Vierimaa O, Kiuru M, Isola J, Roth S, Pukkala E, Sistonen P, Herva R, Aaltonen LA. Inherited susceptibility to uterine leiomyomas and renal cell cancer. Proc Natl Acad Sci U S A 2001;98:3387-92.
3. Toro JR, Nickerson ML, Wei MH, Warren MB, Glenn GM, Turner ML, Stewart L, Duray P, Tourre O, Sharma N, Choyke P, Stratton P, Merino M, Walther MM, Linehan WM, Schmidt LS, Zbar B. Mutations in the fumarate hydratase gene cause hereditary leiomyomatosis and renal cell cancer in families in North America. Am J Hum Genet 2003;73:95-106.
4. Wei MH, Toure O, Glenn GM, Pithukpakorn M, Neckers L, Stolle C, Choyke P, Grubb R, Middelton L, Turner ML, Walther MM, Merino MJ, Zbar B, Linehan WM, Toro JR. Novel mutations in FH and expansion of the spectrum of phenotypes expressed in families with hereditary leiomyomatosis and renal cell cancer. J Med Genet 2006;43:18-27.
5. Alam NA, Olpin S, Leigh IM. Fumarate hydratase mutations and predisposition to cutaneous leiomyomas, uterine leiomyomas and renal cancer. Br J Dermatol 2005;153:11-17.
6. Tomlinson IP, Alam NA, Rowan AJ, Barclay E, Jaeger EE, Kelsell D, Leigh I, Gorman P, Lamlum H, Rahman S, Roylance RR, Olpin S, Bevan S, Barker K, Hearle N, Houlston RS, Kiuru M, Lehtonen R, Karhu A, Vilkki S, Laiho P, Eklund C, Vierimaa O, Aittomaki K, Hietala M, Sistonen P, Paetau A, Salovaara R, Herva R, Launonen V, Aaltonen LA. Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer. Nat Genet 2002;30:406-10.
7. Alam NA, Rowan AJ, Wortham NC, Pollard PJ, Mitchell M, Tyrer JP, Barclay E, Calonje E, Manek S, Adams SJ, Bowers PW, Burrows NP, Charles-Holmes R, Cook LJ, Daly BM, Ford GP, Fuller LC, Hadfield-Jones SE, Hardwick N, Highet AS, Keefe M, MacDonald-Hull SP, Potts ED, Crone M, Wilkinson S, Camacho-Martinez F, Jablonska S, Ratnavel R, MacDonald A, Mann RJ, Grice K, Guillet G, Lewis-Jones MS, McGrath H, Seukeran DC, Morrison PJ, Fleming S, Rahman S, Kelsell D, Leigh I, Olpin S, Tomlinson IP. Genetic and functional analyses of FH mutations in multiple cutaneous and uterine leiomyomatosis, hereditary leiomyomatosis and renal cancer, and fumarate hydratase deficiency. Hum Mol Genet 2003;12:1241-52.
8. Martinez-Mir A, Glaser B, Chuang GS, Horev L, Waldman A, Engler DE, Gordon D, Spelman LJ, Hatzibougias I, Green J, Christiano AM, Zlotogorski A. Germline fumarate hydratase mutations in families with multiple cutaneous and uterine leiomyomata. J Invest Dermatol 2003;121:741-4.
9. Alam NA, Olpin S, Rowan A, Kelsell D, Leigh IM, Tomlinson IP, Weaver T. Missense mutations in fumarate hydratase in multiple cutaneous and uterine leiomyomatosis and renal cell cancer. J Mol Diagn 2005;7:437-43.
10. Chan I, Wong T, Martinez-Mir A, Christiano AM, McGrath JA. Familial multiple cutaneous and uterine leiomyomas associated with papillary renal cell cancer. Clin Exp Dermatol 2005;30:75-8.
11. Matyakhina L, Freedman RJ, Bourdeau I, Wei MH, Stergiopoulos SG, Chidakel A, Walther M, Abu-Asab M, Tsokos M, Keil M, Toro J, Linehan WM, Stratakis CA. Hereditary leiomyomatosis associated with bilateral, massive, macronodular adrenocortical disease and atypical cushing syndrome: a clinical and molecular genetic investigation. J Clin Endocrinol Metab 2005;90:3773-9.
12. Badeloe S, van Geel M, van Steensel MA, Bastida J, Ferrando J, Steijlen PM, Frank J, Poblete-Gutierrez P. Diffuse and segmental variants of cutaneous leiomyomatosis: novel mutations in the fumarate hydratase gene and review of the literature. Exp Dermatol 2006;15:735-41.
13. Chuang GS, Martinez-Mir A, Engler DE, Gmyrek RF, Zlotogorski A, Christiano AM. Multiple cutaneous and uterine leiomyomata resulting from missense mutations in the fumarate hydratase gene. Clin Exp Dermatol 2006;31:118-21.
14. Pithukpakorn M, Wei MH, Toure O, Steinbach PJ, Glenn GM, Zbar B, Linehan WM, Toro JR. Fumarate hydratase enzyme activity in lymphoblastoid cells and fibroblasts of individuals in families with hereditary leiomyomatosis and renal cell cancer. J Med Genet 2006;43:755-62.
15. Ylisaukko-oja SK, Kiuru M, Lehtonen HJ, Lehtonen R, Pukkala E, Arola J, Launonen V, Aaltonen LA. Analysis of fumarate hydratase mutations in a population-based series of early onset uterine leiomyosarcoma patients. Int J Cancer 2006;119:283-7.
16. Campione E, Terrinoni A, Orlandi A, Codispoti A, Melino G, Bianchi L, Mazzotta A, Garaci FG, Ludovici A, Chimenti S. Cerebral cavernomas in a family with multiple cutaneous and uterine leiomyomas associated with a new mutation in the fumarate hydratase gene. J Invest Dermatol 2007;127:2271-3.
17. Lehtonen HJ, Blanco I, Piulats JM, Herva R, Launonen V, Aaltonen LA. Conventional renal cancer in a patient with fumarate hydratase mutation. Hum Pathol 2007;38:793-6.
18. Makino T, Nagasaki A, Furuichi M, Matsui K, Watanabe H, Sawamura D, Shimizu H, Shimizu T. Novel mutation in a fumalate hydratase gene of a Japanese patient with multiple cutaneous and uterine leiomyomatosis. J Dermatol Sci 2007;48:151-3.
19. Ahvenainen T, Lehtonen HJ, Lehtonen R, Vahteristo P, Aittomaki K, Baynam G, Dommering C, Eng C, Gruber SB, Gronberg H, Harvima R, Herva R, Hietala M, Kujala M, Kaariainen H, Sunde L, Vierimaa O, Pollard PJ, Tomlinson IP, Bjorck E, Aaltonen LA, Launonen V. Mutation screening of fumarate hydratase by multiplex ligation-dependent probe amplification: detection of exonic deletion in a patient with leiomyomatosis and renal cell cancer. Cancer Genet Cytogenet 2008;183:83-8.
20. Badeloe S, Bladergroen RS, Jonkman MF, Burrows NP, Steijlen PM, Poblete-Gutierrez P, van Steensel MA, van Geel M, Frank J. Hereditary multiple cutaneous leiomyoma resulting from novel mutations in the fumarate hydratase gene. J Dermatol Sci 2008;51:139-43.
21. Bayley JP, Launonen V, Tomlinson IP. The FH mutation database: an online database of fumarate hydratase mutations involved in the MCUL (HLRCC) tumor syndrome and congenital fumarase deficiency. BMC Med Genet 2008;9:20.
22. Huter E, Wortham NC, Hartschuh W, Enk A, Jappe U. Single base mutation in the fumarate hydratase gene leading to segmental cutaneous leiomyomatosis. Acta Derm Venereol 2008;88:63-5.
23. Onder M, Glenn G, Adisen E, Keseroglu O, Sahin S, Ataoglu O, Akkaya B, Toro JR. Cutaneous papules, uterine fibroids, and renal cell cancer: one family's tale. Lancet 2010;375:170.
24. Vahteristo P, Koski TA, Naatsaari L, Kiuru M, Karhu A, Herva R, Sallinen SL, Vierimaa O, Bjorck E, Richard S, Gardie B, Bessis D, Van Glabeke E, Blanco I, Houlston R, Senter L, Hietala M, Aittomaki K, Aaltonen LA, Launonen V, Lehtonen R. No evidence for a genetic modifier for renal cell cancer risk in HLRCC syndrome. Fam Cancer 2010;9:245-51.
25. Merino MJ, Torres-Cabala C, Pinto P, Linehan WM. The morphologic spectrum of kidney tumors in hereditary leiomyomatosis and renal cell carcinoma (HLRCC) syndrome. Am J Surg Pathol 2007;31:1578-85.
26. Yang XJ, Tan MH, Kim HL, Ditlev JA, Betten MW, Png CE, Kort EJ, Futami K, Furge KA, Takahashi M, Kanayama HO, Tan PH, Teh BS, Luan C, Wang K, Pins M, Tretiakova M, Anema J, Kahnoski R, Nicol T, Stadler W, Vogelzang NG, Amato R, Seligson D, Figlin R, Belldegrun A, Rogers CG, Teh BT. A molecular classification of papillary renal cell carcinoma. Cancer Res 2005;65:5628-37.
27. Bourgeron T, Chretien D, Poggi-Bach J, Doonan S, Rabier D, Letouze P, Munnich A, Rotig A, Landrieu P, Rustin P. Mutation of the fumarase gene in two siblings with progressive encephalopathy and fumarase deficiency. J Clin Invest 1994;93:2514-18.
28. Coughlin EM, Christensen E, Kunz PL, Krishnamoorthy KS, Walker V, Dennis NR, Chalmers RA, Elpeleg ON, Whelan D, Pollitt RJ, Ramesh V, Mandell R, Shih VE. Molecular analysis and prenatal diagnosis of human fumarase deficiency. Mol Genet Metab 1998;63:254-62.
29. Gellera C, Uziel G, Rimoldi M, Zeviani M, Laverda A, Carrara F, DiDonato S. Fumarase deficiency is an autosomal recessive encephalopathy affecting both the mitochondrial and the cytosolic enzymes. Neurology 1990;40:495-9.
30. Weaver TM, Levitt DG, Donnelly MI, Stevens PP, Banaszak LJ. The multisubunit active site of fumarase C from Escherichia coli. Nat Struct Biol 1995;2:654-62.
31. Weaver T, Lees M, Zaitsev V, Zaitseva I, Duke E, Lindley P, McSweeny S, Svensson A, Keruchenko J, Keruchenko I, Gladilin K, Banaszak L. Crystal structures of native and recombinant yeast fumarase. J Mol Biol 1998;280:431-42.
32. Isaacs JS, Jung YJ, Mole DR, Lee S, Torres-Cabala C, Chung YL, Merino M, Trepel J, Zbar B, Toro J, Ratcliffe PJ, Linehan WM, Neckers L. HIF overexpression correlates with biallelic loss of fumarate hydratase in renal cancer: novel role of fumarate in regulation of HIF stability. Cancer Cell 2005;8:143-53.
33. Pollard PJ, Briere JJ, Alam NA, Barwell J, Barclay E, Wortham NC, Hunt T, Mitchell M, Olpin S, Moat SJ, Hargreaves IP, Heales SJ, Chung YL, Griffiths JR, Dalgleish A, McGrath JA, Gleeson MJ, Hodgson SV, Poulsom R, Rustin P, Tomlinson IP. Accumulation of Krebs cycle intermediates and over-expression of HIF1alpha in tumours which result from germline FH and SDH mutations. Hum Mol Genet 2005;14:2231-9.
34. Pollard PJ, Spencer-Dene B, Shukla D, Howarth K, Nye E, El-Bahrawy M, Deheragoda M, Joannou M, McDonald S, Martin A, Igarashi P, Varsani-Brown S, Rosewell I, Poulsom R, Maxwell P, Stamp GW, Tomlinson IP. Targeted inactivation of fh1 causes proliferative renal cyst development and activation of the hypoxia pathway. Cancer Cell 2007;11:311-19.
35. Sudarshan S, Sourbier C, Kong HS, Block K, Valera Romero VA, Yang Y, Galindo C, Mollapour M, Scroggins B, Goode N, Lee MJ, Gourlay CW, Trepel J, Linehan WM, Neckers L. Fumarate hydratase deficiency in renal cancer induces glycolytic addiction and hypoxia-inducible transcription factor 1alpha stabilization by glucose-dependent generation of reactive oxygen species. Mol Cell Biol 2009;29:4080-90.
36. Kiuru M, Lehtonen R, Arola J, Salovaara R, Jarvinen H, Aittomaki K, Sjoberg J, Visakorpi T, Knuutila S, Isola J, Delahunt B, Herva R, Launonen V, Karhu A, Aaltonen LA. Few FH mutations in sporadic counterparts of tumor types observed in hereditary leiomyomatosis and renal cell cancer families. Cancer Res 2002;62:4554-7.
37. Parmentier L, Tomlinson I, Happle R, Borradori L. Evidence for a new fumarate hydratase gene mutation in a unilateral type 2 segmental leiomyomatosis. Dermatology 2010;221:149-53.
38. Smit DL, Mensenkamp AR, Badeloe S, Breuning MH, Simon ME, van Spaendonck KY, Aalfs CM, Post JG, Shanley S, Krapels IP, Hoefsloot LH, van Moorselaar RJ, Starink TM, Bayley JP, Frank J, van Steensel MA, Menko FH. Hereditary leiomyomatosis and renal cell cancer in families referred for fumarate hydratase germline mutation analysis. Clin Genet 2011;79:49-59.
39. Chuang GS, Martinez-Mir A, Geyer A, Engler DE, Glaser B, Cserhalmi-Friedman PB, Gordon D, Horev L, Lukash B, Herman E, Cid MP, Brenner S, Landau M, Sprecher E, Garcia Muret MP, Christiano AM, Zlotogorski A. Germline fumarate hydratase mutations and evidence for a founder mutation underlying multiple cutaneous and uterine leiomyomata. J Am Acad Dermatol 2005;52:410-16.
40. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001;25:402-8.
41. Hill RLa B. R.A. Fumarase: [EC 4.2.1.2 L-Malate hydro-lyase]. Methods Enzymol 1969;13:91-9.
42. Rustin P, Chretien D, Bourgeron T, Gerard B, Rotig A, Saudubray JM, Munnich A. Biochemical and molecular investigations in respiratory chain deficiencies. Clin Chim Acta 1994;228:35-51.
43. Marque M, Gardie B, Bressac de Paillerets B, Rustin P, Guillot B, Richard S, Bessis D. Novel FH mutation in a patient with cutaneous leiomyomatosis associated with cutis verticis gyrata, eruptive collagenoma and Charcot-Marie-Tooth's disease. Br J Dermatol 2010;163:1337-9.
44. Lorenzato A, Olivero M, Perro M, Briere JJ, Rustin P, Di Renzo MF. A cancerpredisposing "hot spot" mutation of the fumarase gene creates a dominant negative protein. Int J Cancer 2008;122:947-51.
45. Choueiri TK, Plantade A, Elson P, Negrier S, Ravaud A, Oudard S, Zhou M, Rini BI, Bukowski RM, Escudier B. Efficacy of sunitinib and sorafenib in metastatic papillary and chromophobe renal cell carcinoma. J Clin Oncol 2008;26:127-31.